Chengcheng Ren

786 total citations
13 papers, 629 citations indexed

About

Chengcheng Ren is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chengcheng Ren has authored 13 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Chengcheng Ren's work include Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Chengcheng Ren is often cited by papers focused on Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Chengcheng Ren collaborates with scholars based in China and United States. Chengcheng Ren's co-authors include Guangmei Zhang, Chengcheng Gao, Tian Liang, Juncheng Dai, Jiangbo Du, Y. Ding, Zhibin Hu, Chuanlong Zhu, Yongming Xu and Guangfu Jin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Chengcheng Ren

12 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengcheng Ren China 12 514 444 75 49 42 13 629
Ting‐Qing Gan China 15 471 0.9× 420 0.9× 70 0.9× 60 1.2× 19 0.5× 30 578
Deyao Wu China 14 615 1.2× 587 1.3× 70 0.9× 65 1.3× 57 1.4× 19 748
Liping Nie China 10 383 0.7× 308 0.7× 86 1.1× 41 0.8× 22 0.5× 18 509
Shun‐Quan Wu China 11 520 1.0× 460 1.0× 65 0.9× 22 0.4× 19 0.5× 25 643
Mohammadreza Hajjari Iran 12 755 1.5× 738 1.7× 52 0.7× 40 0.8× 44 1.0× 46 896
Mingxin Wen China 10 520 1.0× 229 0.5× 167 2.2× 47 1.0× 33 0.8× 17 615
Kei Ihira Japan 15 556 1.1× 485 1.1× 107 1.4× 42 0.9× 22 0.5× 23 704

Countries citing papers authored by Chengcheng Ren

Since Specialization
Citations

This map shows the geographic impact of Chengcheng Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengcheng Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengcheng Ren more than expected).

Fields of papers citing papers by Chengcheng Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengcheng Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengcheng Ren. The network helps show where Chengcheng Ren may publish in the future.

Co-authorship network of co-authors of Chengcheng Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Chengcheng Ren. A scholar is included among the top collaborators of Chengcheng Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengcheng Ren. Chengcheng Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wang, Miao, Ying Cao, Chengcheng Ren, et al.. (2025). PTRF Confers Melanoma‐Acquired Drug Resistance Through the Upregulation of EGFR. Cell Proliferation. 59(2). e70086–e70086.
2.
Jin, Ketao, Chengcheng Ren, Yuyao Liu, Huanrong Lan, & Zhen Wang. (2020). An update on colorectal cancer microenvironment, epigenetic and immunotherapy. International Immunopharmacology. 89(Pt A). 107041–107041. 58 indexed citations
3.
Zhang, Qian, Ning Liu, Junjie Bai, et al.. (2020). Human telomerase reverse transcriptase is a novel target of Hippo‐YAP pathway. The FASEB Journal. 34(3). 4178–4188. 15 indexed citations
4.
Tian, Liang, Liru Li, Yan Cheng, Chengcheng Ren, & Guangmei Zhang. (2016). MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12. OncoTargets and Therapy. Volume 9. 4307–4315. 34 indexed citations
5.
Wu, Di, Lei Liu, Chengcheng Ren, et al.. (2016). Epithelial-mesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer. Oncology Letters. 11(2). 1463–1468. 25 indexed citations
6.
Ren, Chengcheng, Zheng‐Xiang Li, Tianzhen Wang, et al.. (2015). Functions and Mechanisms of Long Noncoding RNAs in Ovarian Cancer. International Journal of Gynecological Cancer. 25(4). 566–569. 74 indexed citations
7.
Wang, Guangyu, Ran Zhao, Dong Wang, et al.. (2015). MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib. Oncology Letters. 10(5). 2835–2841. 18 indexed citations
8.
Wang, Tianzhen, Chengcheng Ren, Lei Liu, et al.. (2015). Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin. Oncology Letters. 11(2). 1189–1194. 42 indexed citations
9.
Guo, Qiuyan, Yan Cheng, Tian Liang, et al.. (2015). Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Scientific Reports. 5(1). 17683–17683. 91 indexed citations
10.
Zhu, Chuanlong, Chengcheng Ren, Jie Han, et al.. (2014). A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. British Journal of Cancer. 110(9). 2291–2299. 191 indexed citations
11.
Gao, Chengcheng, et al.. (2012). Dickkopf-1 Expression Is a Novel Prognostic Marker for Gastric Cancer. SHILAP Revista de lepidopterología. 2012. 1–7. 22 indexed citations
12.
Gao, Chengcheng, et al.. (2011). Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient. Medical Oncology. 29(3). 1733–1738. 48 indexed citations
13.
Gao, Chengcheng, et al.. (2011). Prognostic Value of Raf Kinase Inhibitor Protein in Esophageal Squamous Cell Carcinoma. Pathology & Oncology Research. 18(2). 471–477. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026